Neurological Manifestations and Experience with IV Immunoglobulin in Children with Enterovirus 71 Infections

다국어 초록 (Multilingual Abstract)

Purpose:The objective of the study was to report the neurological manifestations and response to high-dose immunoglobulin (IVIG) therapy in children with enterovirus 71 (EV 71) infections.
Methods:Eleven patients who had the primary clinical marker for enteroviral infection-herpangina or hand-foot-mouth-disease (HFMD) followed by acute neurological manifestations were admitted to Ajou University Hospital from June to September, 2009. All patients were positive for enterovirus (EV) as indicated by reverse transcription polymerase chain reaction (RT-PCR). Among them, EV 71 was confirmed by semi-nested PCR in five patients. All patients received IVIG soon after admission.
Results:The mean age of the patients who were EV 71 positive was 2.5 years (range, 4 months to 5.3 years). Five neurological complications associated with EV 71 infection were identified: meningoencephalitis (3 patients); acute cerebellar ataxia (1 pationt); and complex febrile seizure in another patient. Three patients (60%) had HFMD, and two(40%) had herpangina. None of the patients had neurological sequelae at follow- up.
Conclusion:EV 71 infection should be suspected in young children with epidemic HFMD or herpangina complicated by a variety of neurological manifestations. We have reported the response to high dose IVIG therapy in children with EV 71 infection.

참고문헌 (Reference)

1 Nagington J, "Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit" 2 : 443-446, 1983

2 Valduss D, "Use of intravenous immunoglobulin in twin neonates with disseminated coxsacke B1 infection" 32 : 561-563, 1993

3 Haley M, "The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis" 37 : 88-90, 2003

4 Wong KT, "The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways" 67 : 162-169, 2008

5 Nix WA, "Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens" 44 : 2698-2704, 2006

6 Caramello P, "Role of intravenous immunoglobulin administration in Japanese encephalitis" 43 : 1620-1621, 2006

7 Verstrepen WA, "Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real- time reverse transcription-PCR assay" 39 : 4093-4096, 2001

8 Nagata N, "Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71" 67 : 207-216, 2002

9 Wu CN, "Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus" 20 : 895-904, 2001

10 Lin TY, "Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system" 36 : 269-274, 2003

11 Komatsu H, "Outbreak of severe neurologic involvement associated with enterovirus 71 infection" 20 : 17-23, 1999

12 Wang SM, "Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71 associated brainstem encephalitis" 37 : 47-52, 2006

13 Aertsens M, "Modelling of silica diffusion experiments with 32Si in Boom Clay" 61 : 117-129, 2003

14 Jin F, "Mechanisms of intravenous immunoblobulin action in immune thrombocytopenic purpura" 66 : 403-410, 2005

15 Johnston JM, "Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection" 8 : 254-256, 1989

16 Lum LC, "Fatal enterovirus 71 encephalomyelitis" 133 : 795-798, 1998

17 Solomon T, "Exotic and emerging viral encephalitides" 16 : 411-418, 2003

18 Cho EY, "Epidemics of aseptic meningitis in Seoul area during 1989-90" 34 : 1565-1572, 1991

19 Rotbart HA, "Enteroviral infections of the central nervous system" 20 : 971-981, 1995

20 Chen TC, "Development of antiviral agents for enteroviruses" 62 : 1169-1173, 2008

21 National instutute of health Korea Center for Disease Control & Prevention (KCDC), "Case reports and genetic identification of serious infections by enterovirus 71 in Korea" KCDC 329-399, 2009

22 Galama JM, "Antibodies against enteroviruses in intravenous Ig preparations; great variation in titres and poor correlation with the incidence of circulating serotypes" 53 : 273-276, 1997

23 Ho M, "An epidemic of enterovirus 71 infection in Taiwan" 341 : 929-935, 1999

24 Gieron-Korthals MA, "Acute childhood ataxia: 10-year experience" 9 : 381-384, 1994

25 Chen YC, "A murine oral enterovirus 71 infection model with central nervous system involvement" 85 : 69-77, 2004

26 Moon WY, "A clinical study on aseptic meningitis combined with polio-like paralysis" 36 : 485-494, 1993